Sep 06, 2024
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
| Returns Type | 1 Month (%) | 6 Months (%) | 1 Year (%) | 3 Years (%) | 5 Years (%) | Since Inception (%) |
|---|---|---|---|---|
| Scheme - Nippon India Pharma Fund (G) | 6.79 | 21.77 | 48.63 | 18.08 |
| Benchmark - S&P BSE Healthcare | 14.73 | 38.57 | 53.75 | 13.45 |
| Category Average - BEST EQUITY PERFORMERS | 5.27 | 18.81 | 41.81 | 20.01 |
| Category Rank | 7/4 | 6/4 | 6/4 | 7/4 |
| Fund Name | Nav () | Chg (%) | 1Y Return(%) | 3Y Return(%) | 5Y Return(%) | AUM ( in Crs) | Exp. Ratio (%) | Min.Invst() | Action |
|---|---|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund (IDCW) | 10.5543 | 1.51 | 15.35 | 0.00 | 0.00 | 364.34 | 2.43 | 500.00 | invest |
| Nippon India Taiwan Equity Fund (G) | 10.5543 | 1.51 | 15.35 | 0.00 | 0.00 | 364.34 | 2.43 | 500.00 | invest |
| Quant Healthcare Fund - Regular (G) | 17.3620 | 0.23 | 61.27 | 0.00 | 0.00 | 348.91 | 2.37 | 5,000.00 | invest |
| Quant Healthcare Fund - Regular (IDCW) | 17.3633 | 0.23 | 61.27 | 0.00 | 0.00 | 348.91 | 2.37 | 5,000.00 | invest |
| SBI PSU Fund (G) | 32.9531 | -2.31 | 67.86 | 38.86 | 28.38 | 4,601.76 | 1.87 | 5,000.00 | invest |
| Company Name | As on Date | Invested Amt (Cr) | % Portfolio Weight | Change (%) (Invested Amt.) |
4 Months Trends |
|---|---|---|---|---|---|
| Equity-Sun Pharma.Inds. | Aug 31, 2024 | 1,194.34 | 13.81 | 5.95 |
|
| Equity-Lupin | Aug 31, 2024 | 717.69 | 8.30 | 17.17 |
|
| Equity-Divi`s Lab. | Aug 31, 2024 | 688.09 | 7.96 | 3.47 |
|
| Equity-Cipla | Aug 31, 2024 | 513.02 | 5.93 | 7.16 |
|
| Equity-Dr Reddy`s Labs | Aug 31, 2024 | 492.22 | 5.69 | 4.16 |
|
| Equity-Apollo Hospitals | Aug 31, 2024 | 449.45 | 5.20 | 4.72 |
|
| Equity-Ajanta Pharma | Aug 31, 2024 | 311.16 | 3.60 | 20.35 |
|
| Equity-Gland Pharma | Aug 31, 2024 | 275.78 | 3.19 | -14.15 |
|
| Equity-Vijaya Diagnost. | Aug 31, 2024 | 276.26 | 3.19 | 15.42 |
|
| Equity-Aurobindo Pharma | Aug 31, 2024 | 267.21 | 3.09 | 3.47 |
|
Nippon India Mutual Fund has announced that Mr. Chetan Desai has been appoi...
Nippon India Mutual Fund has introduced the Nippon India Nifty 500 Equal We...
Nippon India Mutual Fund has announced change in Fund Managers of the follo...
Nippon India Mutual Fund has filed draft documents for Active Momentum Fund...
Nippon India Mutual Fund has announced 14 August 2024 as the record date fo...
Nippon India Mutual Fund has announced change in exit load structure under ...
| AMC Name | : | Nippon India Mutual Fund |
| Fund Name | : | Nippon India Pharma Fund (G) |
| Contact Persone | : | Sailesh Raj Bhan |
| Registered Address | : | 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013. |
| Telephone No | : | 022-68087000/1860260111 |
| Fax No. | : | 022-68087097 |
| : | customercare:nipponindiaim.in | |
| Website | : | mf.nipponindiaim.com |
Top Mutual Funds
